Targeted Delivery of Anti‐miR‐712 by VCAM1‐Binding Au Nanospheres for Atherosclerosis Therapy

Tianmeng Sun,Rachel Simmons,Da Huo,Bo Pang,Xin Zhao,Chan Woo Kim,Hanjoong Jo,Younan Xia
DOI: https://doi.org/10.1002/cnma.201600043
IF: 3.82
2016-01-01
ChemNanoMat
Abstract:Atherosclerosis is a chronic, inflammatory disease of the vascular wall, which preferentially develops in regions under disturbed flow (d-flow). Once inflamed, the endothelial cells initiate a signaling cascade that culminates in the expression of pro-atherogenic genes such as mRNAs and miRNAs. Here we demonstrate that vascular cell adhesion molecule 1 (VCAM1), which is highly expressed on the surface of endothelial cells under d-flow, can serve as a marker for the targeted delivery of drug to the inflamed endothelium. We could selectively deliver anti-miR-712, an inhibitor of a key pro-atherogenic miRNA, to VCAM1-expressing immortalized mouse aortic endothelial cells (iMAECs) by hybridizing the inhibitor with a carrier DNA that has a complementary sequence and is conjugated to the surface of Au nanospheres. Our results suggest that the combination of VCAM1-binding peptide and Au nanosphere could provide an effective strategy for the selective delivery of anti-athero-miRNAs or other drugs into inflamed endothelium for the purpose of inhibiting the formation of atherosclerotic plaques.
What problem does this paper attempt to address?